Cour Pharmaceuticals

Cour gets $105M, pharma help to ‘reprogram’ autoimmune disease
BioPharma Dive
Tue, 01/30/24 - 11:10 am
Cour Pharmaceuticals
funding
autoimmune disease
Roche
Pfizer
Bristol Myers Squibb
nanoparticles
FDA Accepts Investigational New Drug Application for Peanut Allergy Candidate Developed by COUR Pharmaceuticals
Drugs.com
Thu, 09/16/21 - 10:42 pm
Cour Pharmaceuticals
peanut allergy
clinical trials
CNP-201
FDA